SEPTInvestingStart Free

OKYO 6-K: SEC filing

OKYO Pharma

Filed with the SEC on · accession 0001493152-26-051159

OKYO filed a 6-K (foreign company report) with the SEC on Nov 12, 2026. How foreign companies listed in the US report news and events — like an 8-K for them.

Summary of the filing

OKYO Pharma announced it will participate in the 2026 Jefferies Global Healthcare Conference in London from November 16-19, 2026, with leadership available for one-on-one investor meetings.

For details, click here →How to read a 6-K →

Key details

RegistrantOKYO Pharma LTD
Conference hostJefferies
Chief financial officerKeeren Shah

✦ Ask GOAX AI about this filing — what it means for OKYO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for OKYO?

Click here

Frequently asked questions

What did OKYO file with the SEC on Nov 12, 2026?

OKYO filed a 6-K (SEC filing). OKYO Pharma announced it will participate in the 2026 Jefferies Global Healthcare Conference in London from November 16-19, 2026, with leadership available for one-on-one investor meetings.

How do I read a 6-K?

How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.

Other OKYO SEC filings

Get alerts when OKYO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
OKYO overviewOKYO analysisOKYO newsLatest SEC filings